Page 680 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 680

658   PART IV     Specific Malignancies in the Small Animal Patient



          TABLE 31.1     World Health Organization Classification and Frequency of Primary Brain Tumors in Dogs and Cats
                                                                                                a
  VetBooks.ir  Tissue of Origin  Tumor Types/Grades                    Canine Frequency of Tumor Diagnosis  3,5,6,21–23
                                                                                              Feline
                                                                            1,2,5–7,20,21,24,25
            Meninges
                                 •   Grade I
                                Meningioma                             42%–52%                40%–59%
                                 •   Grade II (atypical)
                                 •   Grade III (malignant)
            Neuroepithelium   Astrocytic tumors                        13%–60%                <1%–3%
                                 •   Grade I (pilocytic)
                                 •   Grade II (diffuse)
                                 •   Grade III (anaplastic)
                                 •   Grade IV (glioblastoma)
                              Oligodendroglial tumors                  1%–23%                 <1%–3%
                                 •   Grade II (oligodendroglioma)
                                 •   Grade III (anaplastic)
                              Oligoastrocytic tumors                   <5%                    NA
                                 •   Grade II (oligoastrocytoma)
                                 •   Grade III (anaplastic)
                              Choroid plexus tumors                    5%–8%                  <1%
                                 •   Grade I (papilloma)
                                 •   Grade II (atypical papilloma)
                                 •   Grade III (carcinoma)
                              Embryonal tumors                         <0.5%                  <1%
                                 •   Primitive neuroectodermal tumor (Grade IV)
                              Ependymoma                               0.2%–6%                3%
                                 •   Grade II (ependymoma)
                                 •   Grade III (anaplastic)
            a Frequency of diagnosis among all primary brain tumors.
            NA, data not available.



         canine intracranial tumors, with hemangiosarcoma (HSA, 29%–  the region revealing single nucleotide variants in three neighbor-
         35%), pituitary tumors (11%–25%), lymphoma (12%–20%),   ing genes DENR, CAMKK2, and P2RX7 that are highly associ-
                                                                                       23
         and metastatic carcinomas (11%–20%) accounting for 77% to   ated with glioma susceptibility.  The CAMKK2 and P2RX7 genes
         86% of all SBTs. 1,4                                  have been previously recognized as relevant to the development or
                                                                                       23
            Brain tumors in dogs may occur at any age and in any breed   progression of human cancers.  
         with no reported sex predispositions. Most PBTs and SBTs occur
         in middle-aged to older dogs, with the majority of cases described   Cats
         being greater than 5 years of age. Pooled data from the most cur-
         rent retrospective studies indicate that the median ages at diag-  Intracranial tumors are less common in cats compared with dogs.
         nosis for dogs with meningiomas, gliomas, and CPTs were 10.5   Approximately 70% of all feline intracranial tumors are PBTs
         years, 8.0 years, and 5.5 years, respectively. 1,2,20,21  There is a pro-  and more than 50% of PBTs in cats are meningiomas. 3,6,15  Other
         pensity for PBTs in juvenile animals to be neuroepithelial tumors   types of PBTs, such as ependymomas, gliomas, and choroid plexus
         of glial, neuronal, or embryonal origin. 1,22  One study identified a   tumors, are infrequently reported (see Table 31.1). 3,6,15  The most
         significant linear relationship between age and body weight and   common SBTs in cats are lymphoma and pituitary tumors, which
         the occurrence of PBTs; large-breed dogs were at significantly   accounted for nearly 50% and 30%, respectively, of all feline SBTs
         increased risk for developing meningiomas and CPTs.  Golden   in one study.  The median age at diagnosis of cats with menin-
                                                                          3
                                                     1
         retrievers, boxers, miniature schnauzers, and rat terriers have   gioma is 11 years, whereas neuroepithelial tumors and lymphoma
         been identified as breeds in which intracranial meningiomas are   are typically seen in cats in the 7- to 8-year age range. 3,24  There
         overrepresented. 1,2,19,20                            are no known breed or sex predilections for cats to develop brain
            Although CPTs were overrepresented in golden retrievers in   tumors. 
                  21
         one report,  this breed predisposition was not corroborated in a
                             1
         subsequent investigation.  Gliomas (astrocytomas and oligoden-  Pathophysiology, History, and Clinical Signs
         drogliomas) are highly overrepresented in brachycephalic breeds
         including boxers, Boston terrier, bullmastiffs, and English and   PBTs and SBTs are space-occupying intracranial lesions that cause
                      1,2
         French bulldogs.  A recent study has also identified a locus on   clinical signs of brain dysfunction by directly compressing or invad-
         canine chromosome (CFA) 26 that is strongly associated with   ing brain tissue and indirectly through secondary effects, such as
         glioma across multiple dog breeds, with subsequent mapping of   induction of peritumoral edema, neuroinflammation, obstructive
   675   676   677   678   679   680   681   682   683   684   685